Literature DB >> 25126789

Reactivation of developmentally silenced globin genes by forced chromatin looping.

Wulan Deng1, Jeremy W Rupon2, Ivan Krivega3, Laura Breda4, Irene Motta4, Kristen S Jahn2, Andreas Reik5, Philip D Gregory5, Stefano Rivella6, Ann Dean3, Gerd A Blobel7.   

Abstract

Distal enhancers commonly contact target promoters via chromatin looping. In erythroid cells, the locus control region (LCR) contacts β-type globin genes in a developmental stage-specific manner to stimulate transcription. Previously, we induced LCR-promoter looping by tethering the self-association domain (SA) of Ldb1 to the β-globin promoter via artificial zinc fingers. Here, we show that targeting the SA to a developmentally silenced embryonic globin gene in adult murine erythroblasts triggers its transcriptional reactivation. This activity depends on the LCR, consistent with an LCR-promoter looping mechanism. Strikingly, targeting the SA to the fetal γ-globin promoter in primary adult human erythroblasts increases γ-globin promoter-LCR contacts, stimulating transcription to approximately 85% of total β-globin synthesis, with a reciprocal reduction in adult β-globin expression. Our findings demonstrate that forced chromatin looping can override a stringent developmental gene expression program and suggest a novel approach to control the balance of globin gene transcription for therapeutic applications.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25126789      PMCID: PMC4134511          DOI: 10.1016/j.cell.2014.05.050

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  52 in total

1.  Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6.

Authors:  Jian Xu; Vijay G Sankaran; Min Ni; Tobias F Menne; Rishi V Puram; Woojin Kim; Stuart H Orkin
Journal:  Genes Dev       Date:  2010-04-15       Impact factor: 11.361

Review 2.  Beta-globin regulation and long-range interactions.

Authors:  Robert-Jan Palstra; Wouter de Laat; Frank Grosveld
Journal:  Adv Genet       Date:  2008       Impact factor: 1.944

3.  Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.

Authors:  Vijay G Sankaran; Tobias F Menne; Jian Xu; Thomas E Akie; Guillaume Lettre; Ben Van Handel; Hanna K A Mikkola; Joel N Hirschhorn; Alan B Cantor; Stuart H Orkin
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

4.  SCL and associated proteins distinguish active from repressive GATA transcription factor complexes.

Authors:  Tamara Tripic; Wulan Deng; Yong Cheng; Ying Zhang; Christopher R Vakoc; Gregory D Gregory; Ross C Hardison; Gerd A Blobel
Journal:  Blood       Date:  2008-11-14       Impact factor: 22.113

5.  Cell type specificity of chromatin organization mediated by CTCF and cohesin.

Authors:  Chunhui Hou; Ryan Dale; Ann Dean
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

6.  Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease.

Authors:  James E Bradner; Raymond Mak; Shyam K Tanguturi; Ralph Mazitschek; Stephen J Haggarty; Kenneth Ross; Cindy Y Chang; Jocelyn Bosco; Nathan West; Elizabeth Morse; Katherine Lin; John Paul Shen; Nicholas P Kwiatkowski; Nele Gheldof; Job Dekker; Daniel J DeAngelo; Steven A Carr; Stuart L Schreiber; Todd R Golub; Benjamin L Ebert
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

Review 7.  Advances in the understanding of haemoglobin switching.

Authors:  Vijay G Sankaran; Jian Xu; Stuart H Orkin
Journal:  Br J Haematol       Date:  2010-03-01       Impact factor: 6.998

8.  A zinc-finger transcriptional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts.

Authors:  Andrew Wilber; Ulrich Tschulena; Phillip W Hargrove; Yoon-Sang Kim; Derek A Persons; Carlos F Barbas; Arthur W Nienhuis
Journal:  Blood       Date:  2010-02-26       Impact factor: 22.113

9.  Developmental and species-divergent globin switching are driven by BCL11A.

Authors:  Vijay G Sankaran; Jian Xu; Tobias Ragoczy; Gregory C Ippolito; Carl R Walkley; Shanna D Maika; Yuko Fujiwara; Masafumi Ito; Mark Groudine; M A Bender; Philip W Tucker; Stuart H Orkin
Journal:  Nature       Date:  2009-08-05       Impact factor: 49.962

10.  A positive role for NLI/Ldb1 in long-range beta-globin locus control region function.

Authors:  Sang-Hyun Song; Chunhui Hou; Ann Dean
Journal:  Mol Cell       Date:  2007-12-14       Impact factor: 17.970

View more
  173 in total

1.  SIRT1 activates the expression of fetal hemoglobin genes.

Authors:  Yan Dai; Tyngwei Chen; Heba Ijaz; Elizabeth H Cho; Martin H Steinberg
Journal:  Am J Hematol       Date:  2017-08-28       Impact factor: 10.047

2.  GATA1 directly mediates interactions with closely spaced pseudopalindromic but not distantly spaced double GATA sites on DNA.

Authors:  Lorna Wilkinson-White; Krystal L Lester; Nina Ripin; David A Jacques; J Mitchell Guss; Jacqueline M Matthews
Journal:  Protein Sci       Date:  2015-08-20       Impact factor: 6.725

3.  Pharmacologic control of chromatin looping.

Authors:  Marjorie Brand
Journal:  Blood       Date:  2015-07-30       Impact factor: 22.113

Review 4.  Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.

Authors:  Megan D Hoban; Stuart H Orkin; Daniel E Bauer
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

5.  CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.

Authors:  Cody C Wyles; Christopher R Paradise; Matthew T Houdek; Susan L Slager; Andre Terzic; Atta Behfar; Andre J van Wijnen; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2019-08       Impact factor: 4.176

6.  NRF2 mediates γ-globin gene regulation through epigenetic modifications in a β-YAC transgenic mouse model.

Authors:  Xingguo Zhu; Caixia Xi; Alexander Ward; Mayuko Takezaki; Huidong Shi; Kenneth R Peterson; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-26

7.  The LDB1 Complex Co-opts CTCF for Erythroid Lineage-Specific Long-Range Enhancer Interactions.

Authors:  Jongjoo Lee; Ivan Krivega; Ryan K Dale; Ann Dean
Journal:  Cell Rep       Date:  2017-06-20       Impact factor: 9.423

Review 8.  Enhancer deregulation in cancer and other diseases.

Authors:  Hans-Martin Herz
Journal:  Bioessays       Date:  2016-08-29       Impact factor: 4.345

Review 9.  Oxidative Stress in β-Thalassemia.

Authors:  Eitan Fibach; Mutaz Dana
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

Review 10.  Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges.

Authors:  Valentina Ghiaccio; Maxwell Chappell; Stefano Rivella; Laura Breda
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.